As of 2025-10-16, the EV/EBITDA ratio of agilon health Inc (AGL) is -0.93. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AGL's latest enterprise value is 286.24 mil USD. AGL's TTM EBITDA according to its financial statements is -308.37 mil USD. Dividing these 2 quantities gives us the above AGL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 12.7x | 11.8x |
| Forward P/E multiples | 11.6x - 12.5x | 12.3x |
| Fair Price | (8.30) - (8.96) | (8.66) |
| Upside | -913.9% - -978.1% | -948.6% |
| Date | EV/EBITDA |
| 2025-10-14 | -0.79 |
| 2025-10-13 | -0.75 |
| 2025-10-10 | -0.83 |
| 2025-10-09 | -0.93 |
| 2025-10-08 | -1.02 |
| 2025-10-07 | -0.98 |
| 2025-10-06 | -1.06 |
| 2025-10-03 | -1.08 |
| 2025-10-02 | -1.01 |
| 2025-10-01 | -0.90 |
| 2025-09-30 | -0.94 |
| 2025-09-29 | -1.05 |
| 2025-09-26 | -1.02 |
| 2025-09-25 | -1.02 |
| 2025-09-24 | -1.10 |
| 2025-09-23 | -1.05 |
| 2025-09-22 | -1.08 |
| 2025-09-19 | -1.12 |
| 2025-09-18 | -1.13 |
| 2025-09-17 | -1.09 |
| 2025-09-16 | -1.06 |
| 2025-09-15 | -1.05 |
| 2025-09-12 | -1.00 |
| 2025-09-11 | -1.01 |
| 2025-09-10 | -1.08 |
| 2025-09-09 | -1.10 |
| 2025-09-08 | -1.25 |
| 2025-09-05 | -1.17 |
| 2025-09-04 | -1.18 |
| 2025-09-03 | -1.17 |
| 2025-09-02 | -1.26 |
| 2025-08-29 | -1.28 |
| 2025-08-28 | -1.26 |
| 2025-08-27 | -1.30 |
| 2025-08-26 | -1.21 |
| 2025-08-25 | -1.41 |
| 2025-08-22 | -1.34 |
| 2025-08-21 | -1.21 |
| 2025-08-20 | -1.18 |
| 2025-08-19 | -1.24 |
| 2025-08-18 | -1.21 |
| 2025-08-15 | -1.05 |
| 2025-08-14 | -0.98 |
| 2025-08-13 | -0.97 |
| 2025-08-12 | -0.76 |
| 2025-08-11 | -0.72 |
| 2025-08-08 | -0.73 |
| 2025-08-07 | -0.73 |
| 2025-08-06 | -0.75 |
| 2025-08-05 | -0.74 |